Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tachykinin receptor 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K04224 tachykinin receptor 3, putative | Get druggable targets OG5_137770 | All targets in OG5_137770 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.002 | 0.3745 | 0.1038 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.3745 | 0.1038 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.0036 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 1 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.3745 | 0.1038 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0036 | 1 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.3745 | 0.1038 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.5661 | 0.3064 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0036 | 1 | 1 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.0036 | 1 | 1 |
Plasmodium falciparum | pyruvate kinase | 0.0036 | 1 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0036 | 1 | 1 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0036 | 1 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0036 | 1 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.0036 | 1 | 1 |
Mycobacterium ulcerans | pyruvate kinase | 0.0036 | 1 | 1 |
Giardia lamblia | Pyruvate kinase | 0.0036 | 1 | 1 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0036 | 1 | 0.5 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.002 | 0.3745 | 0.1038 |
Loa Loa (eye worm) | pyruvate kinase | 0.0036 | 1 | 1 |
Leishmania major | pyruvate kinase | 0.0036 | 1 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.002 | 0.3745 | 0.1038 |
Plasmodium vivax | pyruvate kinase, putative | 0.0036 | 1 | 1 |
Loa Loa (eye worm) | pyruvate kinase-PB | 0.0025 | 0.5661 | 0.3064 |
Leishmania major | pyruvate kinase | 0.0036 | 1 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.002 | 0.3745 | 0.3745 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0036 | 1 | 0.5 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.0036 | 1 | 1 |
Echinococcus multilocularis | pyruvate kinase | 0.0029 | 0.6979 | 0.5671 |
Loa Loa (eye worm) | pyruvate kinase | 0.0036 | 1 | 1 |
Echinococcus multilocularis | pyruvate kinase | 0.0036 | 1 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.0036 | 1 | 1 |
Trypanosoma brucei | pyruvate kinase 1 | 0.0036 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.3745 | 0.1038 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0036 | 1 | 0.5 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0036 | 1 | 0.5 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0036 | 1 | 1 |
Entamoeba histolytica | pyruvate kinase, putative | 0.0025 | 0.5661 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.002 | 0.3745 | 0.5 |
Chlamydia trachomatis | pyruvate kinase | 0.0036 | 1 | 0.5 |
Schistosoma mansoni | pyruvate kinase | 0.0036 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.002 | 0.3745 | 0.5 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0036 | 1 | 1 |
Echinococcus multilocularis | pyruvate kinase | 0.0036 | 1 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.002 | 0.3745 | 0.1038 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 170 nM | Ability to displace [125I]-substance P from hNK1 receptor in chinese hamster ovarian (CHO) cells | ChEMBL. | 9873445 |
IC50 (binding) | = 170 nM | Ability to displace [125I]-substance P from hNK1 receptor in chinese hamster ovarian (CHO) cells | ChEMBL. | 9873445 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.